HCV DAA Eligibility: Simplified direct-acting antiviral eligibility for treatment-naive hepatitis C pathways.
Treatment-naive
+2 Points
No decompensated cirrhosis
No active HBV coinfection concern
+1 Points
No major DAA drug interaction flag
Pregnancy or major contraindication
-2 Points
Can complete monitoring/follow-up
Assessment Tier
Score 0
A more complex hepatitis C treatment pathway is likely required.